Boston Scientific (BSX) Tops Q3 EPS by 4c; offers guidance
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $44.33 --0%
EPS Growth %: +10.7%
Financial Fact:
Royalty expense: 20M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +10.7%
Financial Fact:
Royalty expense: 20M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.63, $0.04 better than the analyst estimate of $0.59. Revenue for the quarter came in at $4.21 billion versus the consensus estimate of $4.04 billion.
GUIDANCE:
Boston Scientific sees Q4 2024 EPS of $0.64-$0.66, versus the consensus of $0.64.
Boston Scientific sees FY2024 EPS of $2.45-$2.47, versus the consensus of $2.41.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- BE Semiconductor (BESI:NA) (BESIY) PT Raised to EUR400 at Needham
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
